White Paper: Developing Global Trademarks: Benchmarking Strategy & Process
This study excerpt is a sample from a 40-slide study that identifies the strategies and processes used by leading companies to develop global trademarks. The entire study is available for resale in the best Practice Database.
Best Practices, LLC surveyed 13 pharmaceutical or biotechnology companies to compare strategies and processes to developing global trademarks. Executives with seven of these companies were also interviewed to discuss their approaches and lessons learned.
This research was conducted on behalf of the Business Excellence Board -- a membership-based research and advisory service.
Industries Profiled:
Medical Device; Pharmaceutical; Biotech; Health Care
Companies Profiled:
3M Pharmaceuticals; Sanofi-aventis; AstraZeneca; Eli Lilly; Genzyme; Johnson & Johnson; Merck; Navigant; Pfizer; Schering-Plough
|